ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

6.26%

$5.60

Market Cap $86.68M

Healthcare Medical Devices

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AVR	Application for quotation of securities - AVR		23/02/22	32.22KB	Share
AVR	L1 Capital Exercises Options		23/02/22	161.32KB	Share
AVR	Ceasing to be a substantial holder		16/02/22	941.06KB	Share
AVR	Merger Proposal Update	PRICE SENSITIVE	15/02/22	164.83KB	Share
AVR	Notification regarding unquoted securities - AVR		14/02/22	29.37KB	Share
AVR	Becoming a substantial holder		08/02/22	590.32KB	Share
AVR	Cleansing Notice		08/02/22	159.76KB	Share
AVR	Proposal to Negotiate Non-Binding Letter of Intent - Merger	PRICE SENSITIVE	08/02/22	147.82KB	Share
AVR	Application for quotation of securities - AVR		07/02/22	32.19KB	Share
AVR	Cleansing Notice		27/01/22	159.92KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/01/22	330.46KB	Share
AVR	Application for quotation of securities - AVR		27/01/22	29.44KB	Share
AVR	Successful Interim Results for the First-In-Human Trial	PRICE SENSITIVE	24/01/22	214.96KB	Share
AVR	Notification of cessation of securities - AVR		12/01/22	22.95KB	Share
AVR	Cleansing Notice		11/01/22	159.74KB	Share
AVR	Application for quotation of securities - AVR		10/01/22	26.73KB	Share
AVR	New Patent Application for ADAPT		05/01/22	157.13KB	Share
AVR	Cleansing Notice		29/12/21	161.55KB	Share
AVR	Appendix 3G		29/12/21	363.68KB	Share
AVR	Appendix 2A		29/12/21	383.03KB	Share
AVR	Exercise of Underwritten Listed Options		29/12/21	161.54KB	Share
AVR	Appendix 2A		24/12/21	384.25KB	Share
AVR	Appendix 2A		24/12/21	307.36KB	Share
AVR	Appendix 3G		24/12/21	364.4KB	Share
AVR	Change in substantial holding		22/12/21	1MB	Share
AVR	Appendix 2A		17/12/21	378.26KB	Share
AVR	Results of Meeting		16/12/21	181.18KB	Share
AVR	Repayment of Facility Agreement		16/12/21	161.95KB	Share
AVR	Application for quotation of securities - AVR		15/12/21	26.73KB	Share
AVR	Application for quotation of securities - AVR		10/12/21	26.72KB	Share
AVR	Change of Director's Interest Notice		07/12/21	513.95KB	Share
AVR	Proposed issue of securities - AVR		07/12/21	25.81KB	Share
AVR	Underwriting Agreement - AVRO Listed Options	PRICE SENSITIVE	07/12/21	160.86KB	Share
AVR	Trading Halt	PRICE SENSITIVE	06/12/21	224.09KB	Share
AVR	Application for quotation of securities - AVR		03/12/21	26.72KB	Share
AVR	Notification of cessation of securities - AVR		01/12/21	22.95KB	Share
AVR	DurAVR First in Human Patient Study Follow Up		01/12/21	143.21KB	Share
AVR	DurAVR THV Featured at PCR London Valves		30/11/21	173.61KB	Share
AVR	Application for quotation of securities - AVR		26/11/21	26.72KB	Share
AVR	Change in substantial holding		24/11/21	1.06MB	Share
AVR	Application for quotation of securities - AVR		22/11/21	26.73KB	Share
AVR	Notification of cessation of securities - AVR		22/11/21	22.86KB	Share
AVR	Five TAVR Patients Successfully Implanted With DurAVR Valve	PRICE SENSITIVE	22/11/21	170.89KB	Share
AVR	Notification of Expiry of Listed Options		17/11/21	512.54KB	Share
AVR	Notification regarding unquoted securities - AVR		16/11/21	29.34KB	Share
AVR	Application for quotation of securities - AVR		15/11/21	26.72KB	Share
AVR	Notice of Extraordinary General Meeting/Proxy Form		15/11/21	849.82KB	Share
AVR	DurAVR selected for PCR London Valves Innovation Session		08/11/21	202.08KB	Share
AVR	Becoming a substantial holder		03/11/21	145.09KB	Share
AVR	Cleansing Notice		01/11/21	160.35KB	Share
AVR	Notification regarding unquoted securities - AVR		01/11/21	26.02KB	Share
AVR	Application for quotation of securities - AVR		01/11/21	27.09KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/21	383.94KB	Share
AVR	Proposed issue of securities - AVR		27/10/21	42.2KB	Share
AVR	Capital Raise	PRICE SENSITIVE	27/10/21	173.09KB	Share
AVR	DurAVR accepted into TCT Innovation session		18/10/21	166.2KB	Share
AVR	Key Partnerships		12/10/21	193.3KB	Share
AVR	Key Animal Study for EFS Submission Completed		05/10/21	185.68KB	Share
AVR	Notification regarding unquoted securities - AVR		30/09/21	29.77KB	Share
AVR	Notification regarding unquoted securities - AVR		29/09/21	29.99KB	Share
AVR	Results of Meeting		23/09/21	179.26KB	Share
AVR	Application for quotation of securities - AVR		16/09/21	26.67KB	Share
AVR	Notification regarding unquoted securities - AVR		15/09/21	33.23KB	Share
AVR	Notification of cessation of securities - AVR		06/09/21	23.42KB	Share
AVR	Chief Medical Officer Appointment		06/09/21	166.35KB	Share
AVR	Extended Manufacturing Agreement		30/08/21	166.78KB	Share
AVR	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	26/08/21	956.51KB	Share
AVR	Notice of Extraordinary General Meeting/Proxy Form		24/08/21	846.45KB	Share
AVR	Notification of cessation of securities - AVR		12/08/21	23.42KB	Share
AVR	Cleansing Notice		10/08/21	181.7KB	Share
AVR	Application for quotation of securities - AVR		10/08/21	26.7KB	Share
AVR	Notification regarding unquoted securities - AVR		02/08/21	29.22KB	Share
AVR	Proposed issue of securities - AVR		02/08/21	30.71KB	Share
AVR	Capital Raise	PRICE SENSITIVE	02/08/21	189.44KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/21	322.86KB	Share
AVR	Trading Halt	PRICE SENSITIVE	29/07/21	631.2KB	Share
AVR	Patent Grant		26/07/21	183.74KB	Share
AVR	DurAVR THV Featured Prominently During TVT 2021		23/07/21	168.24KB	Share
AVR	Ceasing to be a substantial holder		22/07/21	387.03KB	Share
AVR	Notification regarding unquoted securities - AVR		19/07/21	29.22KB	Share
AVR	Constitution		16/07/21	438.95KB	Share
AVR	Results of Meeting		15/07/21	174.33KB	Share
AVR	AGM Chairman's address and CEO Presentation	PRICE SENSITIVE	15/07/21	7.08MB	Share
AVR	ADAPT Manufacturing Breakthrough		12/07/21	156.63KB	Share
AVR	Notification of cessation of securities - AVR		30/06/21	23.33KB	Share
AVR	DurAVR presentation at the TVT 2021 Innovation session		28/06/21	131.11KB	Share
AVR	Application for quotation of securities - AVR		24/06/21	25.83KB	Share
AVR	Notice of Annual General Meeting/Proxy Form		15/06/21	1.08MB	Share
AVR	ADAPT Conduit Proof of Concept Study finds no Calcification	PRICE SENSITIVE	15/06/21	105.26KB	Share
AVR	Change of Director's Interest Notice		10/06/21	261.04KB	Share
AVR	Research & Development Tax Refund		03/06/21	166.79KB	Share
AVR	Becoming a substantial holder		02/06/21	217.33KB	Share
AVR	Cleansing Notice		01/06/21	182.56KB	Share
AVR	Appendix 2A		01/06/21	306.03KB	Share
AVR	Appendix 3G		31/05/21	283.25KB	Share
AVR	Update to Annual General Meeting		26/05/21	136.85KB	Share
AVR	Ceasing to be a substantial holder		24/05/21	227.09KB	Share
AVR	Proposed issue of Securities - AVR		24/05/21	29.79KB	Share
AVR	Capital Raise	PRICE SENSITIVE	24/05/21	164.94KB	Share
AVR	Trading Halt	PRICE SENSITIVE	21/05/21	287.87KB	Share

AVR Application for quotation of securities - AVR
23/02/22		32.22KB	Share
AVR L1 Capital Exercises Options
23/02/22		161.32KB	Share
AVR Ceasing to be a substantial holder
16/02/22		941.06KB	Share
AVR Merger Proposal Update
15/02/22	PRICE SENSITIVE	164.83KB	Share
AVR Notification regarding unquoted securities - AVR
14/02/22		29.37KB	Share
AVR Becoming a substantial holder
08/02/22		590.32KB	Share
AVR Cleansing Notice
08/02/22		159.76KB	Share
AVR Proposal to Negotiate Non-Binding Letter of Intent - Merger
08/02/22	PRICE SENSITIVE	147.82KB	Share
AVR Application for quotation of securities - AVR
07/02/22		32.19KB	Share
AVR Cleansing Notice
27/01/22		159.92KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
27/01/22	PRICE SENSITIVE	330.46KB	Share
AVR Application for quotation of securities - AVR
27/01/22		29.44KB	Share
AVR Successful Interim Results for the First-In-Human Trial
24/01/22	PRICE SENSITIVE	214.96KB	Share
AVR Notification of cessation of securities - AVR
12/01/22		22.95KB	Share
AVR Cleansing Notice
11/01/22		159.74KB	Share
AVR Application for quotation of securities - AVR
10/01/22		26.73KB	Share
AVR New Patent Application for ADAPT
05/01/22		157.13KB	Share
AVR Cleansing Notice
29/12/21		161.55KB	Share
AVR Appendix 3G
29/12/21		363.68KB	Share
AVR Appendix 2A
29/12/21		383.03KB	Share
AVR Exercise of Underwritten Listed Options
29/12/21		161.54KB	Share
AVR Appendix 2A
24/12/21		384.25KB	Share
AVR Appendix 2A
24/12/21		307.36KB	Share
AVR Appendix 3G
24/12/21		364.4KB	Share
AVR Change in substantial holding
22/12/21		1MB	Share
AVR Appendix 2A
17/12/21		378.26KB	Share
AVR Results of Meeting
16/12/21		181.18KB	Share
AVR Repayment of Facility Agreement
16/12/21		161.95KB	Share
AVR Application for quotation of securities - AVR
15/12/21		26.73KB	Share
AVR Application for quotation of securities - AVR
10/12/21		26.72KB	Share
AVR Change of Director's Interest Notice
07/12/21		513.95KB	Share
AVR Proposed issue of securities - AVR
07/12/21		25.81KB	Share
AVR Underwriting Agreement - AVRO Listed Options
07/12/21	PRICE SENSITIVE	160.86KB	Share
AVR Trading Halt
06/12/21	PRICE SENSITIVE	224.09KB	Share
AVR Application for quotation of securities - AVR
03/12/21		26.72KB	Share
AVR Notification of cessation of securities - AVR
01/12/21		22.95KB	Share
AVR DurAVR First in Human Patient Study Follow Up
01/12/21		143.21KB	Share
AVR DurAVR THV Featured at PCR London Valves
30/11/21		173.61KB	Share
AVR Application for quotation of securities - AVR
26/11/21		26.72KB	Share
AVR Change in substantial holding
24/11/21		1.06MB	Share
AVR Application for quotation of securities - AVR
22/11/21		26.73KB	Share
AVR Notification of cessation of securities - AVR
22/11/21		22.86KB	Share
AVR Five TAVR Patients Successfully Implanted With DurAVR Valve
22/11/21	PRICE SENSITIVE	170.89KB	Share
AVR Notification of Expiry of Listed Options
17/11/21		512.54KB	Share
AVR Notification regarding unquoted securities - AVR
16/11/21		29.34KB	Share
AVR Application for quotation of securities - AVR
15/11/21		26.72KB	Share
AVR Notice of Extraordinary General Meeting/Proxy Form
15/11/21		849.82KB	Share
AVR DurAVR selected for PCR London Valves Innovation Session
08/11/21		202.08KB	Share
AVR Becoming a substantial holder
03/11/21		145.09KB	Share
AVR Cleansing Notice
01/11/21		160.35KB	Share
AVR Notification regarding unquoted securities - AVR
01/11/21		26.02KB	Share
AVR Application for quotation of securities - AVR
01/11/21		27.09KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
28/10/21	PRICE SENSITIVE	383.94KB	Share
AVR Proposed issue of securities - AVR
27/10/21		42.2KB	Share
AVR Capital Raise
27/10/21	PRICE SENSITIVE	173.09KB	Share
AVR DurAVR accepted into TCT Innovation session
18/10/21		166.2KB	Share
AVR Key Partnerships
12/10/21		193.3KB	Share
AVR Key Animal Study for EFS Submission Completed
05/10/21		185.68KB	Share
AVR Notification regarding unquoted securities - AVR
30/09/21		29.77KB	Share
AVR Notification regarding unquoted securities - AVR
29/09/21		29.99KB	Share
AVR Results of Meeting
23/09/21		179.26KB	Share
AVR Application for quotation of securities - AVR
16/09/21		26.67KB	Share
AVR Notification regarding unquoted securities - AVR
15/09/21		33.23KB	Share
AVR Notification of cessation of securities - AVR
06/09/21		23.42KB	Share
AVR Chief Medical Officer Appointment
06/09/21		166.35KB	Share
AVR Extended Manufacturing Agreement
30/08/21		166.78KB	Share
AVR Appendix 4D and Half Year Financial Report
26/08/21	PRICE SENSITIVE	956.51KB	Share
AVR Notice of Extraordinary General Meeting/Proxy Form
24/08/21		846.45KB	Share
AVR Notification of cessation of securities - AVR
12/08/21		23.42KB	Share
AVR Cleansing Notice
10/08/21		181.7KB	Share
AVR Application for quotation of securities - AVR
10/08/21		26.7KB	Share
AVR Notification regarding unquoted securities - AVR
02/08/21		29.22KB	Share
AVR Proposed issue of securities - AVR
02/08/21		30.71KB	Share
AVR Capital Raise
02/08/21	PRICE SENSITIVE	189.44KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
30/07/21	PRICE SENSITIVE	322.86KB	Share
AVR Trading Halt
29/07/21	PRICE SENSITIVE	631.2KB	Share
AVR Patent Grant
26/07/21		183.74KB	Share
AVR DurAVR THV Featured Prominently During TVT 2021
23/07/21		168.24KB	Share
AVR Ceasing to be a substantial holder
22/07/21		387.03KB	Share
AVR Notification regarding unquoted securities - AVR
19/07/21		29.22KB	Share
AVR Constitution
16/07/21		438.95KB	Share
AVR Results of Meeting
15/07/21		174.33KB	Share
AVR AGM Chairman's address and CEO Presentation
15/07/21	PRICE SENSITIVE	7.08MB	Share
AVR ADAPT Manufacturing Breakthrough
12/07/21		156.63KB	Share
AVR Notification of cessation of securities - AVR
30/06/21		23.33KB	Share
AVR DurAVR presentation at the TVT 2021 Innovation session
28/06/21		131.11KB	Share
AVR Application for quotation of securities - AVR
24/06/21		25.83KB	Share
AVR Notice of Annual General Meeting/Proxy Form
15/06/21		1.08MB	Share
AVR ADAPT Conduit Proof of Concept Study finds no Calcification
15/06/21	PRICE SENSITIVE	105.26KB	Share
AVR Change of Director's Interest Notice
10/06/21		261.04KB	Share
AVR Research & Development Tax Refund
03/06/21		166.79KB	Share
AVR Becoming a substantial holder
02/06/21		217.33KB	Share
AVR Cleansing Notice
01/06/21		182.56KB	Share
AVR Appendix 2A
01/06/21		306.03KB	Share
AVR Appendix 3G
31/05/21		283.25KB	Share
AVR Update to Annual General Meeting
26/05/21		136.85KB	Share
AVR Ceasing to be a substantial holder
24/05/21		227.09KB	Share
AVR Proposed issue of Securities - AVR
24/05/21		29.79KB	Share
AVR Capital Raise
24/05/21	PRICE SENSITIVE	164.94KB	Share
AVR Trading Halt
21/05/21	PRICE SENSITIVE	287.87KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.60		Change 0.330(6.26%)		Mkt cap ! $86.68M

Open	High	Low	Value	Volume
$5.50	$5.60	$5.30	$89.45K	16.14K

Buyers (Bids)

No.	Vol.	Price($)
1	103	$5.30

Sellers (Offers)

Price($)	Vol.	No.
$5.98	992	1

View Market Depth

No.	Vol.	Price($)
1	103	5.300
1	920	5.270
1	613	5.240
1	576	5.200
1	20000	5.150

Price($)	Vol.	No.
5.980	992	1
5.990	3500	1
6.000	3719	2
6.050	20000	1
6.500	230	2

Last trade - 15.29pm 22/08/2025 (20 minute delay)

AVR (ASX) Chart

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

Corporate Spotlight
Not Yet Available